Acquisitions (Tables)

9 Months Ended

Sep. 30, 2022

BioFlex And NTM Acquisition

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents	$	2,870
Accounts receivable		1,408
Inventory		741
Prepaid expenses and other current assets		126
Property and equipment		34
Operating lease right of use asset		1,034
Customer relationships		13,240
Developed technology		3,540
Trademark and tradename		310
Non-competition agreements		60
Goodwill		9,804
Long term deferred tax asset		111
Accounts payable		(224	)
Accrued liabilities		(450	)
Operating lease liability		(1,030	)
Operating lease liability, long-term		(3	)
Fair value of net assets acquired	$	31,571

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the NTM Acquisition and their estimated useful lives:

	Useful life	Fair Value
		(Amounts in thousands)
Customer relationships	10 years	$	13,240
Developed technology	11 years		3,540
Trademark and tradename	15 years		310
Non-competition agreements	3 years		60
		$	17,150

Avitide, Inc.

Schedule of Business Combination Consideration Transferred

Total consideration transferred is as follows (amounts in thousands):

Cash consideration	$	74,962
Equity consideration		82,968
Contingent consideration - earnout		88,373
Fair value of net assets acquired	$	246,303

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and final allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents	$	572
Accounts receivable		228
Inventory		332
Prepaid expenses and other current assets		114
Property and equipment		1,862
Operating lease right of use asset		3,648
Customer relationships		24,580
Developed technology		20,650
Trademark and tradename		1,210
Non-competition agreements		210
Goodwill		197,476
Long term deferred tax asset		1,525
Accounts payable		(215	)
Accrued liabilities		(2,183	)
Operating lease liability		(698	)
Operating lease liability, long-term		(2,950	)
Other liabilities		(58	)
Fair value of net assets acquired	$	246,303

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Avitide Acquisition and their estimated useful lives:

	Useful life	Fair Value
		(Amounts in thousands)
Customer relationships	13 years	$	24,580
Developed technology	15 years		20,650
Trademark and tradename	18 years		1,210
Non-competition agreements	3 years		210
		$	46,650

Polymem S.A.

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and final allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents	$	353
Net working capital (excluding cash and inventory      step-up)		414
Inventory step-up		543
Operating lease right of use assets		1,424
Property and equipment		3,145
Other assets		41
Developed technology		8,274
Trademark and tradenames		510
Non-compete agreements		312
Goodwill		35,680
Operating lease liability		(1,253	)
Long term deferred tax liability		(2,327	)
Other long-term liabilities		(143	)
Fair value of net assets acquired	$	46,973

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Polymem Acquisition and their estimated useful lives:

	Useful life	Fair Value
		(Amounts in thousands)
Developed technology	13 years	$	8,274
Trademark and tradename	14 years		510
Non-competition agreements	5 years		312
		$	9,096